|
Options
| ShowHide Related Items >><< - 12/22/20
- Pharmacy stocks lower after DoJ files prescription drug suit against Walmart
- 12/21/20
- Rite Aid expands no-charge COVID-19 testing capabilities
- 12/17/20
- Rite Aid rises 17.4%
- 12/17/20
- Rite Aid rises 28.3%
- 12/18/20 Deutsche Bank
- Rite Aid price target raised to $17 from $9 at Deutsche Bank
- 11/17/20 Oppenheimer
- Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
- 11/17/20 Goldman Sachs
- Goldman says Amazon news likely to pressure entire pharmacy supply chain
- 09/25/20 Deutsche Bank
- Rite Aid price target lowered to $9 from $18 at Deutsche Bank
- 12/17/20
- Rite Aid raises FY21 adjusted EPS view to 45c-85c from (67c)-9c, consensus (9c)
- 12/17/20
- Rite Aid reports Q3 continuing operations EPS 8c, consensus (5c)
- 12/17/20
- Rite Aid reports Q3 adjusted EPS 40c, consensus (5c)
- 12/16/20
- Notable companies reporting before tomorrow's open
- 07/28/20
- Rite Aid used facial recognition tech in hundreds of U.S. stores, Reuters says
- 12/17/20
- Fly Intel: Wall Street's top stories for Thursday
- 12/17/20
- Fly Intel: Wall Street's top stories at midday
- 12/17/20
- Fly Intel: Pre-market Movers
- 11/17/20
- Fly Intel: Wall Street's top stories for Tuesday
- 09:40 Today
- Unusually active option classes on open January 25th
- 12/21/20
- Rite Aid call volume above normal and directionally bullish
- 12/17/20
- Unusually active option classes on open December 17th
- 11/27/20
- Rite Aid put volume heavy and directionally bearish
|
|
Upgrade
| ShowHide Related Items >><< - 01/11/21
- Passage Bio says PBGM01 entering clinic to study safety, efficacy
- 01/11/21
- Passage Bio announces corporate outlook
- 01/07/21
- Passage Bio gets FDA orphan drug designation in frontotemporal dementia
- 01/04/21
- Passage Bio receives FDA clearance of IND for PBGM01
- 06:37 Today Wedbush
- Passage Bio initiated with an Outperform at Wedbush
- 01/04/21 Chardan
- Lifting hold on PGBM01 a 'broad positive' for Passage Bio pipeline, says Chardan
- 01/04/21 JPMorgan
- Passage Bio upgraded to Overweight at JPMorgan after clinical hold lifted
- 01/04/21 JPMorgan
- Passage Bio upgraded to Overweight from Neutral at JPMorgan
- 11/10/20
- Passage Bio reports Q3 EPS (63c), consensus (76c)
- 08/13/20
- Passage Bio reports Q2 EPS (60c), consensus (57c)
|
|
Hot Stocks
| ShowHide Related Items >><< - $1,885.31 /
-16.56 (-0.87%) - 01/22/21
- Alphabet announces plans to wind down Loon
- 01/19/21
- Google Cloud launches Product Discovery Solutions for Retail
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 01/14/21
- Google completes acquisition of Fitbit, commits to protect users' privacy
- $1,880.16 /
-13.43 (-0.71%) - 01/22/21
- Alphabet announces plans to wind down Loon
- 01/19/21
- Google Cloud launches Product Discovery Solutions for Retail
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 01/14/21
- Google completes acquisition of Fitbit, commits to protect users' privacy
- $1,885.31 /
-16.56 (-0.87%) - 08:44 Today Morgan Stanley
- Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
- 08:15 Today Canaccord
- Alphabet price target raised to $2250 from $2050 at Canaccord
- 07:09 Today Mizuho
- Alphabet price target raised to $2,100 from $1,810 at Mizuho
- 01/21/21
- Fly Intel: Top five analyst initiations
- $1,880.16 /
-13.43 (-0.71%) - 08:44 Today Morgan Stanley
- Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
- 07:09 Today Mizuho
- Alphabet price target raised to $2,100 from $1,810 at Mizuho
- 01/21/21
- Fly Intel: Top five analyst initiations
- 01/20/21 Piper Sandler
- Alphabet assumed with an Overweight at Piper Sandler
- $1,885.31 /
-16.56 (-0.87%) - 10/29/20
- Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago
- 10/29/20
- Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago
- 10/29/20
- Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago
- 10/29/20
- Alphabet reports Q3 EPS $16.40, consensus $11.29
- $1,880.16 /
-13.43 (-0.71%) - 10/29/20
- Alphabet CFO sees signs user behavior beginning to return to normalized level
- 10/29/20
- Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago
- 10/29/20
- Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago
- 10/29/20
- Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago
- $1,885.31 /
-16.56 (-0.87%) - 01/23/21
- Big tech stocks are back, Barron's says
- 01/22/21
- YouTube enables HDR support on Xbox gaming systems, Verge reports
- 01/22/21
- Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports
- 01/22/21
- Google threatens to close search engine in Australia over news plans, FT reports
- $1,880.16 /
-13.43 (-0.71%) - 01/23/21
- Big tech stocks are back, Barron's says
- 01/22/21
- YouTube enables HDR support on Xbox gaming systems, Verge reports
- 01/22/21
- Waymo CEO: Tesla Autopilot will fall short of full autonomy, Bloomberg reports
- 01/22/21
- Google threatens to close search engine in Australia over news plans, FT reports
- $1,885.31 /
-16.56 (-0.87%) - 01/21/21
- Snap initiation, PayPal upgrade among today's top calls on Wall Street
- 01/20/21
- #SocialStocks: Facebook could be in focus under new administration
- 01/19/21
- Game On: An exclusive talk with The Game Bakers' Emeric Thoa
- 01/13/21
- #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler
- $1,880.16 /
-13.43 (-0.71%) - 01/21/21
- Snap initiation, PayPal upgrade among today's top calls on Wall Street
- 01/20/21
- #SocialStocks: Facebook could be in focus under new administration
- 01/19/21
- Game On: An exclusive talk with The Game Bakers' Emeric Thoa
- 01/13/21
- #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler
- $1,885.31 /
-16.56 (-0.87%) - 11/10/20
- Alphabet call volume above normal and directionally bullish
- 10/30/20
- Early notable gainers among liquid option names on October 30th
- $1,880.16 /
-13.43 (-0.71%) - 01/20/21
- Early notable gainers among liquid option names on January 20th
- 10/30/20
- Early notable gainers among liquid option names on October 30th
- 10/21/20
- Unusually active option classes on open October 21st
- 08/27/20
- Alphabet Class A call volume above normal and directionally bullish
|
|
Options
| ShowHide Related Items >><< - 01/08/21
- Boot Barn not providing Q4, FY21 guidance amid COVID-19 uncertainty
- 10/28/20
- Boot Barn says Q3 'started well' retail store SSS improving to flat
- 08/14/20
- Boot Barn promotes Greg Hackman to COO
- 08/05/20
- Boot Barn rises 16.6%
- 01/22/21 Williams Capital
- Boot Barn initiated with a Buy at Williams Trading
- 01/14/21 JPMorgan
- Boot Barn price target raised to $63 from $60 at JPMorgan
- 01/12/21 Cowen
- Boot Barn price target raised to $65 from $47 at Cowen
- 01/11/21 Craig-Hallum
- Boot Barn price target raised to $48 from $34 at Craig-Hallum
- 13:55 Today
- Notable companies reporting after market close
- 01/08/21
- Boot Barn reports preliminary Q3 EPS $1.00, consensus 83c
- 10/28/20
- Boot Barn reports Q2 EPS 20c, consensus 12c
- 08/04/20
- Boot Barn reports Q1 EPS (2c), consensus (17c)
- 01/06/21
- Before the Move: Analysts make pre-announcement predictions ahead of ICR event
- 11/17/20
- American initiation, Moderna downgrade among today's top calls on Wall Street
- 10/28/20
- Fly Intel: After-Hours Movers
- 08/04/20
- Fly Intel: After-Hours Movers
|
|
On The Fly
|
Welcome to "Fly Insider,"… ShowHide Related Items >><< - 12/15/20
- Burning Rock Biotech, OncoCyte enter exclusive DetermaRx licensing agreement
- 11/18/20
- OncoCyte presents data on DetermaIO test at AMP conference
- 10/20/20
- OncoCyte says Q3 DetermaRx testing volume rose to 175 billable samples
- 10/14/20
- OncoCyte to present new prospective data on DetermaRx
- 01/21/21
- Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors
- 01/07/21
- Aldeyra announces top-line results from run-in cohort in Tranquility study
- 12/22/20
- Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612
- 12/17/20
- Aldeyra initiates Phase 2 trials of ADX-629
HCDI Harbor Custom Development - 01/22/21
- Harbor Custom Development acquires land for $9.4M in Austin area
- 10/19/20
- Harbor Custom Development appoints Wally Walker to board of directors
- 10/06/20
- Harbor Custom Development secures $11M in construction funding
- 09/24/20
- Harbor Custom Development enters purchase, sale agreement for WA property
- 07/27/20
- Amkor Technology up over 9% at $14.90 per share after Q2 results and Q3 guidance
- 01/04/21
- AssetMark Financial closes $250M revolving credit facility
- 10/12/20
- AssetMark Financial reports platform assets $67.3B at the end of Sept., up 16.2%
- 09/10/20
- AssetMark reports platform assets of $68B at the end of August, up 19.1%
- 08/18/20
- AssetMark Financial launches eService team, expands digital servicing tools
- 08:10 Today
- AMSC awarded contract for ship protection system on LPD-29
- 11/03/20
- AMSC announces $15M of new energy power system orders
- 10/05/20
- AMSC acquires NEPSI for $26M in cash, 873,657 restricted shares
ATSG Air Transport Services - 12/30/20
- ABX Air pilots ratify amendment to Collective Bargaining Agreement
- 12/06/20
- ABX Air reaches tentative agreement with Pilot Union
- 11/11/20
- Air Transport Services delivers Boeing 767 freighter to Cargojet
- 09/24/20
- GE Aviation selected by Air Transport Services for digital agreement
- 01/05/21 Benchmark
- GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
- 12/17/20 BTIG
- BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
- 12/16/20 Piper Sandler
- OncoCyte upgraded to Overweight from Neutral at Piper Sandler
- 11/30/20 BTIG
- OncoCyte initiated with a Buy at BTIG
- 01/08/21 Jefferies
- Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies
- 01/08/21 Citi
- Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi
- 01/07/21 Alliance Global Partners
- Aldeyra in an 'enviable position' after Phase 3 Tranquility data, says AGP
- 12/16/20 Berenberg
- Berenberg starts Aldeyra with Buy, sees near-term catalysts
HCDI Harbor Custom Development - 06:38 Today Citi
- Citi moves Marvell up to pick in semiconductor equipment
- 06:28 Today Citi
- Amkor Technology price target raised to $13 from $11.40 at Citi
- 11/19/20 Citi
- Citi moves Lam Research, Marvell to top picks in Semi Equipment
- 10/27/20 Deutsche Bank
- Amkor Technology price target raised to $16 from $14 at Deutsche Bank
- 12/18/20 Truist
- AssetMark Financial initiated with a Hold at Truist
- 09/23/20 Jefferies
- AssetMark Financial initiated with a Hold at Jefferies
- 08/05/20 JPMorgan
- AssetMark Financial downgraded on growth slowdown at JPMorgan
- 08/05/20 JPMorgan
- AssetMark Financial downgraded to Neutral from Overweight at JPMorgan
- 11/06/20 Canaccord
- AMSC downgraded to Hold at Canaccord
- 11/06/20 Canaccord
- AMSC downgraded to Hold from Buy at Canaccord
- 11/05/20 Roth Capital
- AMSC price target raised to $20 from $18 at Roth Capital
- 10/07/20 Craig-Hallum
- AMSC price target raised to $21 from $15 at Craig-Hallum
ATSG Air Transport Services - 10/12/20 Loop Capital
- Air Transport Services upgraded to Buy from Hold at Loop Capital
- 06/04/20 Stephens
- Amazon leases more proof of strong demand for Air Transport, says Stephens
- 05/01/20 SunTrust
- Air Transport Services initiated with a Buy at SunTrust
- 05/01/20 SunTrust
- Air Transport Services initiated with a Buy at SunTrust
- 11/12/20
- OncoCyte reports Q3 EPS (10c), consensus (9c)
- 11/05/20
- Aldeyra reports Q3 EPS (23c), consensus (27c)
- 08/06/20
- Aldeyra reports Q2 EPS (25c), consensus (34c)
HCDI Harbor Custom Development - 11/23/20
- Harbor Custom Development sees 2021 gross revenues $70M
- 11/23/20
- Harbor Custom Development sees 2020 gross revenues $47M
- 10/26/20
- Amkor Technology sees FY20 CapEx roughly $550M
- 10/26/20
- Amkor Technology sees Q4 EPS 28c-47c, two estimates 23c
- 10/26/20
- Amkor Technology reports Q3 EPS 38c, two estimates 26c
- 07/27/20
- Amkor Technology sees Q3 EPS 17c-35c, two estimates 13c
- 08/04/20
- AssetMark Financial reports Q2 EPS 21c, consensus 22c
- 11/04/20
- AMSC sees Q3 net loss expected not to exceed (21c) p/s, consensus (16c)
- 11/04/20
- AMSC reports Q2 EPS (17c), consensus (18c)
- 11/04/20
- AMSC reports Q2 EPS (17c), consensus (18c)
- 10/05/20
- AMSC reports preliminary Q2 EPS less than (30c), consensus (19c)
ATSG Air Transport Services - 10/29/20
- Air Transport Services raises FY20 adjusted EBITDA view to $490M from $470M
- 10/29/20
- Air Transport Services reports Q3 adjusted EPS 44c, consensus 31c
- 08/05/20
- Air Transport Services sees FY20 adjusted EBITDA at least $470M
- 08/05/20
- Air Transport Services reports Q2 adjusted EPS 47c, consensus 29c
|